Abdominal tourniquet for severe postpartum bleeding
Part of Women’s health & pregnancy clinical trials.
This trial tests a temporary abdominal tourniquet to stop heavy bleeding after childbirth when standard treatments aren't working. It might help women with severe blood loss avoid more invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You are bleeding heavily after childbirth
- Standard medicines and a balloon treatment have not stopped the bleeding
- Your estimated blood loss is more than 1300 mL (about 5.5 cups)
- You are able to give verbal consent before the device is used
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a vacuum-based device to help stop severe bleeding after delivery (postpartum hemorrhage), especially when the uterus is not tightening. It may help women who have ongoing bleeding despite standard first medicines to reduce bleeding.
This trial tests whether a special balloon placed in the womb can stop heavy bleeding after childbirth when standard medicines don't work. This could help avoid more serious surgery and keep you safe.
This trial tests two emergency treatments to control heavy bleeding after childbirth when standard medicines haven't worked. One uses a small balloon placed inside the womb, and the other uses a special gauze that helps blood clot.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.
This study compares two methods to stop heavy bleeding after childbirth. It may help find a more effective way to control bleeding when the uterus does not contract properly.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
Hear when a new Postpartum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.